A pooled analysis of clinical trials and laboratory work found that five months of nicotinamide riboside supplementation correlated with approximately 2.5 years of reduction in muscle epigenetic age, measured by multiple clock algorithms. The finding suggests NAD+ precursor supplementation may influence age-related molecular signatures in skeletal muscle, though the company acknowledges results are preliminary and largely correlational.
Key Points
- NR supplementation associated with 2.5-year muscle epigenetic age reduction
- Six of seven muscle clocks trended lower; blood clocks showed significant reductions
- In vitro NAD+ elevation did not produce significant epigenetic marker changes
Longevity Analysis
Epigenetic clocks measure biological aging independent of chronological time, offering a molecular window into how interventions affect tissue-level aging rates. If confirmed, a measurable reduction in muscle epigenetic age would indicate that NAD+ availability influences the molecular processes underlying sarcopenia and age-related muscle dysfunction—two primary drivers of functional decline. The discrepancy between NAD+ elevation in cell models and the correlation observed in human muscle samples suggests the mechanism may involve systemic or metabolic factors beyond simple NAD+ concentration, warranting investigation of how energy metabolism, mitochondrial function, and tissue regeneration interconnect at the molecular level.
Original published by LT Wire.